Free Trial

CVRx (CVRX) Competitors

CVRx logo
$1.30 -0.09 (-6.47%)
Closing price 04:00 PM Eastern
Extended Trading
$1.31 +0.01 (+0.46%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVRX vs. KRMD, OWLT, APYX, KEQU, and CNXU

Should you buy CVRx stock or one of its competitors? CVRx's main competitors and comparable companies include KORU Medical Systems (KRMD), Owlet (OWLT), Apyx Medical (APYX), Kewaunee Scientific (KEQU), and Conexeu Sciences (CNXU). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does CVRx compare to KORU Medical Systems?

CVRx (NASDAQ:CVRX) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, earnings, risk, valuation and profitability.

KORU Medical Systems has a net margin of -4.03% compared to CVRx's net margin of -84.93%. KORU Medical Systems' return on equity of -10.63% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-84.93% -152.35% -50.93%
KORU Medical Systems -4.03%-10.63%-6.51%

CVRx has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.39, suggesting that its stock price is 61% less volatile than the broader market.

75.3% of CVRx shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CVRx presently has a consensus price target of $4.30, suggesting a potential upside of 230.77%. KORU Medical Systems has a consensus price target of $7.00, suggesting a potential upside of 133.33%. Given CVRx's higher probable upside, research analysts plainly believe CVRx is more favorable than KORU Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
KORU Medical Systems
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.83

KORU Medical Systems has lower revenue, but higher earnings than CVRx. KORU Medical Systems is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$56.65M0.61-$53.31M-$1.98N/A
KORU Medical Systems$41.13M3.35-$2.64M-$0.04N/A

In the previous week, CVRx and CVRx both had 2 articles in the media. KORU Medical Systems' average media sentiment score of 1.27 beat CVRx's score of 0.39 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
KORU Medical Systems
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

KORU Medical Systems beats CVRx on 11 of the 15 factors compared between the two stocks.

How does CVRx compare to Owlet?

Owlet (NYSE:OWLT) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

Owlet has a net margin of -8.61% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
CVRx -84.93%-152.35%-50.93%

Owlet currently has a consensus price target of $15.00, suggesting a potential upside of 238.22%. CVRx has a consensus price target of $4.30, suggesting a potential upside of 209.35%. Given Owlet's stronger consensus rating and higher possible upside, equities analysts plainly believe Owlet is more favorable than CVRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

Owlet has higher revenue and earnings than CVRx. Owlet is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M1.23-$39.68M-$0.75N/A
CVRx$61.19M0.61-$53.31M-$1.98N/A

72.6% of Owlet shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 36.2% of Owlet shares are owned by insiders. Comparatively, 16.6% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Owlet has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market. Comparatively, CVRx has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market.

In the previous week, CVRx had 1 more articles in the media than Owlet. MarketBeat recorded 2 mentions for CVRx and 1 mentions for Owlet. Owlet's average media sentiment score of 1.35 beat CVRx's score of 0.52 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CVRx
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Owlet beats CVRx on 12 of the 16 factors compared between the two stocks.

How does CVRx compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

Apyx Medical has a beta of 1.45, suggesting that its share price is 45% more volatile than the broader market. Comparatively, CVRx has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

In the previous week, CVRx had 2 more articles in the media than Apyx Medical. MarketBeat recorded 2 mentions for CVRx and 0 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.79 beat CVRx's score of 0.39 indicating that Apyx Medical is being referred to more favorably in the media.

Company Overall Sentiment
Apyx Medical Very Positive
CVRx Neutral

55.3% of Apyx Medical shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 15.9% of Apyx Medical shares are owned by insiders. Comparatively, 16.6% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Apyx Medical currently has a consensus target price of $6.50, indicating a potential upside of 154.90%. CVRx has a consensus target price of $4.30, indicating a potential upside of 230.77%. Given CVRx's higher probable upside, analysts clearly believe CVRx is more favorable than Apyx Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Apyx Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

Apyx Medical has a net margin of -14.78% compared to CVRx's net margin of -84.93%. Apyx Medical's return on equity of -76.60% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Apyx Medical-14.78% -76.60% -13.91%
CVRx -84.93%-152.35%-50.93%

Apyx Medical has higher earnings, but lower revenue than CVRx. Apyx Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apyx Medical$52.84M2.03-$11.21M-$0.20N/A
CVRx$56.65M0.61-$53.31M-$1.98N/A

Summary

Apyx Medical beats CVRx on 11 of the 16 factors compared between the two stocks.

How does CVRx compare to Kewaunee Scientific?

CVRx (NASDAQ:CVRX) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

75.3% of CVRx shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 16.6% of CVRx shares are held by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Kewaunee Scientific has a net margin of 2.97% compared to CVRx's net margin of -84.93%. Kewaunee Scientific's return on equity of 11.61% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-84.93% -152.35% -50.93%
Kewaunee Scientific 2.97%11.61%4.82%

CVRx has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

CVRx presently has a consensus price target of $4.30, suggesting a potential upside of 230.77%. Given CVRx's stronger consensus rating and higher possible upside, analysts clearly believe CVRx is more favorable than Kewaunee Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, CVRx and CVRx both had 2 articles in the media. Kewaunee Scientific's average media sentiment score of 0.46 beat CVRx's score of 0.39 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Kewaunee Scientific
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kewaunee Scientific has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$56.65M0.61-$53.31M-$1.98N/A
Kewaunee Scientific$282M0.33$9.62M$2.7611.75

Summary

CVRx and Kewaunee Scientific tied by winning 7 of the 14 factors compared between the two stocks.

How does CVRx compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

In the previous week, Conexeu Sciences had 3 more articles in the media than CVRx. MarketBeat recorded 5 mentions for Conexeu Sciences and 2 mentions for CVRx. CVRx's average media sentiment score of 0.39 beat Conexeu Sciences' score of 0.36 indicating that CVRx is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conexeu Sciences
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CVRx
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Conexeu Sciences has higher earnings, but lower revenue than CVRx. Conexeu Sciences is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conexeu SciencesN/AN/A-$3.92M-$0.40N/A
CVRx$56.65M0.61-$53.31M-$1.98N/A

Conexeu Sciences has a net margin of 0.00% compared to CVRx's net margin of -84.93%. CVRx's return on equity of -152.35% beat Conexeu Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Conexeu SciencesN/A -200.20% -177.26%
CVRx -84.93%-152.35%-50.93%

Conexeu Sciences currently has a consensus target price of $20.00, suggesting a potential upside of 553.59%. CVRx has a consensus target price of $4.30, suggesting a potential upside of 230.77%. Given Conexeu Sciences' higher probable upside, research analysts clearly believe Conexeu Sciences is more favorable than CVRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conexeu Sciences
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
CVRx
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17

75.3% of CVRx shares are owned by institutional investors. 16.6% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

CVRx beats Conexeu Sciences on 8 of the 13 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$37.03M$5.65B$7.36B$12.64B
Dividend YieldN/A1.74%2.51%19.61%
P/E RatioN/A25.17274.1524.84
Price / Sales0.6174.71624.7597.88
Price / CashN/A31.8476.1951.56
Price / Book0.875.7310.295.86
Net Income-$53.31M$146.25M$3.50B$380.67M
7 Day Performance-17.72%-2.67%-5.37%-4.97%
1 Month Performance-56.95%-4.22%-8.55%-6.95%
1 Year Performance-86.33%2.95%0.43%-5.99%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
3.9622 of 5 stars
$1.30
-6.5%
$4.30
+230.8%
-85.6%$37.03M$56.65MN/A223
KRMD
KORU Medical Systems
4.6262 of 5 stars
$3.00
+1.0%
$7.00
+133.3%
-25.7%$137.79M$41.13MN/A73
OWLT
Owlet
2.6276 of 5 stars
$4.62
-0.1%
$15.00
+225.0%
-50.1%$134.85M$105.70MN/A114
APYX
Apyx Medical
3.2779 of 5 stars
$2.60
-1.9%
$6.50
+150.0%
-17.7%$109.51M$52.84MN/A205
KEQU
Kewaunee Scientific
1.3692 of 5 stars
$32.20
-0.6%
N/A-23.7%$93.38M$282M11.671,231

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 10/16/2026 by MarketBeat.com Staff.
From Our Partners